Instituto Nacional de Salud del Niño-Breña.
Universidad San Ignacio de Loyola, Vicerrectorado de Investigación, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud.
Bol Med Hosp Infant Mex. 2023;80(Supl 1):33-39. doi: 10.24875/BMHIM.22000076.
Pulmonary embolism (PE) is a complication reported in the adult population with coronavirus disease 2019 (COVID-19); however, its documentation in the pediatric population is limiteda.
We report the case of a 15-year-old male with obesity and Down syndrome who was admitted for severe COVID-19 pneumonia. On day 7 of admission, he presented with chest pain, hemoptysis, respiratory distress, and marked elevation of D-dimer. Pulmonary CT angiography found an extensive thrombus in the right lower lobar artery. He received treatment with enoxaparin and rivaroxaban and had a favorable clinical outcome. In the tomographic control 1 month after treatment, thrombus was not evidenced and was successfully resolved.
There are few reports of PE in children with COVID-19. Prompt diagnosis and early anticoagulant treatment are important to avoid life-threatening complications.
肺栓塞（PE）是 2019 年冠状病毒病（COVID-19）成年患者中报告的一种并发症；然而，其在儿科人群中的记录有限。
我们报告了一例肥胖合并唐氏综合征的 15 岁男性，因严重 COVID-19 肺炎入院。入院第 7 天，他出现胸痛、咯血、呼吸窘迫和 D-二聚体显著升高。肺部 CT 血管造影发现右下肺叶动脉有广泛血栓。他接受了依诺肝素和利伐沙班治疗，临床结果良好。治疗 1 个月后的断层扫描控制显示，没有血栓证据，血栓成功溶解。
COVID-19 患儿中肺栓塞的报道较少。及时诊断和早期抗凝治疗对于避免危及生命的并发症非常重要。
